C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 405/02 (2006.01) A61K 31/415 (2006.01) C07D 405/06 (2006.01)
Patent
CA 2312965
This invention relates to a new monoargininyl salt form of the endothelin receptor antagonist, (E)-3-[1-n-Butyl-5- [2-(2-carboxyphenyl)methoxy-4- chlorophenyl]- 1H-pyrazol-4-yl]-2- [(5-methoxy-2,3-dihydrobenzofuran- 6- yl)methyl]-prop-2-enoic acid.
L'invention concerne une nouvelle forme de sel monoargininylique de l'antagoniste du récepteur de l'endothéline, (E)-3-[1-n-Butyl- 5[2(2-carboxyphényl)méthoxy-4- chlorophényl]- 1H-pyrazol-4-yl]-2- [(5-méthoxy-2,3-dihydrobenzofuran-6-yl)méthyl]- prop-2-énoïque.
Flisak Joseph Robert
Kearney Albert Stephen
Palepu Nagesh
Perng Cherng-Yih
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
(e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chloropheny... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chloropheny..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chloropheny... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1738406